Natera's fetal genetic testing trial enrolls over 2,000 patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. TSLA

Go back to Natera's fetal genetic testing trial enrolls over 2,000 patients
(NASDAQ: NTRA) Delayed: 212.07 -7.16 (3.27%)
Previous Close $219.23    52 Week High $13.80 
Open $223.71    52 Week Low $6.52 
Day High $223.71    P/E N/A 
Day Low $208.79    EPS $0.00 
Volume 811,715